tiprankstipranks
Trending News
More News >

Gary Pace Insider Profile

25 Followers
Gary Pace, Director at Resmed, holds 2.68M shares in Cardiff Oncology (Ticker: CRDF), holds 22.13K shares in Pacira Pharmaceuticals (Ticker: PCRX), holds 100.58K shares in Resmed (Ticker: RMD). Most recently, Gary Pace Bought ― shares of Cardiff Oncology on Jul 31, 2025 for an estimated value of $710.50K.
tipranks
Gary Pace

Gary Pace
Resmed (RMD)
Director

Ranked #3,489 out of 102,971 Corporate Insiders

Profitable Transactions

38%
8 out of 21 Profitable Transactions

Average Return

+28.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$36M
79.57%
18.13%
1.52%
0.77%
A breakdown of Gary Pace's holdings

Insider Roles

Resmed
(RMD)
Director
Cardiff Oncology
(CRDF)
Director
Pacira Pharmaceuticals
(PCRX)
Director
Imunon
(IMNN)
Director
Roles that Gary Pace holds in companies

Most Profitable Insider Trade

Stock:
Cardiff Oncology
(CRDF)
Rating:Informative Buy
Date:May 13, 2020 - May 13, 2021
Return:+543.10%
The most profitable trade made by Gary Pace

Gary Pace's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Resmed
May 10, 2018
Director
Uninformative Buy
783.35K
$28.65M
Cardiff Oncology
Jul 31, 2025
Director
Informative Buy
710.50K
$6.53M
Pacira Pharmaceuticals
Mar 08, 2024
Director
Informative Sell
3.66M
$548.31K
Imunon
Director
$277.48K
List of latest transactions for each holding click on a transaction to see Gary Pace's performance on stock

Gary Pace insider profile FAQ

What is the percentage of profitable transactions made by Gary Pace?
The percentage of profitable transactions made by Gary Pace is 38%.
    What is the average return per transaction made by Gary Pace?
    The average return per transaction made by Gary Pace is 28.20%.
      What stocks does Gary Pace hold?
      Gary Pace holds: RMD, CRDF, PCRX, IMNN stocks.
        What was Gary Pace’s latest transaction?
        Gary Pace latest transaction was an Informative Buy of $710.50K.
          What was Gary Pace's most profitable transaction?
          Gary Pace’s most profitable transaction was an Informative Buy of CRDF stock on May 13, 2020. The return on the trade was 543.10%.
            What is Gary Pace's role in Resmed?
            Gary Pace's role in Resmed is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.